Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Atypical myopathy testing service launched
sycamore
Atypical myopathy is caused by the ingestion of sycamore tree seeds or seedlings, which contain the toxin hypoglycin-A.

RVC hopes to improve understanding of the condition 

Testing for atypical myopathy is now being offered by the RVC as part of its work to develop improved treatments and management of the disorder.

Atypical myopathy is a life-threatening equine muscle disorder caused by the ingestion of sycamore tree seeds or seedlings, which contain the toxin hypoglycin-A.

The risk factors for horses are unclear. For example, it is not known whether some trees are more toxic than others, or whether the toxin levels vary at certain times of the year, or in certain climates.

Scientists have developed a more rapid test for hypoglycin-A and its principal metabolite MCPA-carnitine. The Comparative Neuromuscular Diseases Laboratory at the RVC is now offering testing for the toxin and its metabolite in serum from horses suspected of having atypical myopathy, or at-risk field companions.

The RVC’s lab also offers urine organic acid and plasma acyl carnitine profile testing, which support the diagnosis in this acquired form of multiple acyl-coA dehydrogenase deficiency. Samples must be submitted by vets.

Samples of sycamore seeds, seedlings and leaves are also being tested for horse owners who have concerns about trees on their properties. Owners can organise this directly with the lab.

Professor Richard Piercy, professor of comparative neuromuscular disease, commented: “Through working with vets and owners in this way and with the support of the Horse Trust and [RVC’s Animal Care Trust], we hope to be able to improve the understanding of the condition and improve the welfare of horses.”

Image courtesy of RVC

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.